What's Happening?
The Marcus Evans 20th Edition Project Portfolio and Resource Management Excellence for Pharma and BioTech conference is scheduled to take place in New Jersey from March 18 to March 19, 2026. This event will bring together leaders from the pharmaceutical and biotechnology sectors to discuss strategies for strengthening portfolio decision-making frameworks. The conference will focus on addressing rising regulatory pressures, investment constraints, and scientific uncertainties. Key topics include governance discipline, cross-functional alignment, and the use of advanced analytics and AI for forecasting and risk assessment. Attendees will have the opportunity to learn from best practices and case studies presented by industry experts from companies
such as Daiichi Sankyo, Novartis, Merck, argenx, AstraZeneca, and Boehringer Ingelheim.
Why It's Important?
The conference is significant as it addresses the critical challenges faced by the pharma and biotech industries, particularly in the context of regulatory compliance and market dynamics. As these sectors are heavily regulated, the ability to effectively manage portfolios can directly impact a company's competitiveness and innovation capacity. By focusing on advanced analytics and AI, the event highlights the industry's shift towards data-driven decision-making, which is essential for navigating complex regulatory environments and optimizing resource allocation. The insights shared at this conference could lead to improved strategic planning and execution, ultimately benefiting stakeholders across the industry, including investors, researchers, and healthcare providers.
What's Next?
Following the conference, participating organizations are expected to implement the strategies and insights gained to enhance their portfolio management practices. This could involve adopting new technologies and methodologies to improve forecasting accuracy and risk management. Additionally, the emphasis on cross-functional engagement and external partnerships may lead to increased collaboration within the industry, fostering innovation and growth. Companies may also focus on building organizational agility to better respond to market disruptions and sustain long-term competitiveness.
